Chris Freeman, Chief Commercial Officer, on May 22, 2026, sold 24,406 shares in Guardant Health (GH) for $2,896,360. Following the Form 4 filing with the SEC, Freeman has control over a total of 60,034 common shares of the company, with 60,034 shares held directly.
SEC Filing: